TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison Between Sitagliptin Add-on Therapy and Insulin Dose Increase Therapy for Uncontrolled Type 2 Diabetes on Insulin Therapy
Brief Summary: It is well established that inhibition of dipeptidyl peptidase (DPP)-IV reduces glucose levels and preserves pancreatic beta cell function in patients with type 2 diabetes. DPP-IV inhibitors stimulate insulin secretion as well as insulin biosynthesis and inhibit glucagon secretion from pancreas by increasing incretin (GLP-1) levels. Recent studies reported that combination therapy with DPP-IV inhibitors and other oral antidiabetic medication have additive or synergistic effects in lowering glycose level, preserving beta-cell mass and function as well as enhancing insulin sensitivity. However, there have been few studies about the glucose lowering effect of DPP-IV inhibitors in patients with type 2 diabetes on insulin treatment.

The researchers hypothesized that DPP-IV inhibitor add-on therapy to insulin treatment may have favorable effects on glucose control and endogenous insulin secretory function in type 2 diabetic patients. The researchers plan to compare between sitagliptin (DPP-IV inhibitor) add-on therapy and insulin dose increase therapy in uncontrolled type 2 diabetes on insulin treatment.


Options:
A: Arm Label: Vildagliptin; Type: EXPERIMENTAL; Interventions: Drug: Vildagliptin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Vildagliptin; Assigned to Arm(s): Vildagliptin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: rosiglitazone; Assigned to Arm(s): N/A
C: Arm Label: sitagliptin; Type: EXPERIMENTAL; Interventions: Drug: sitagliptin | Arm Label: insulin dose increase; Type: ACTIVE_COMPARATOR; Interventions: Drug: insulin dose increase | Intervention Type: DRUG; Name: sitagliptin; Assigned to Arm(s): sitagliptin | Intervention Type: DRUG; Name: insulin dose increase; Assigned to Arm(s): insulin dose increase
D: Arm Label: Standard glycemic control; Type: ACTIVE_COMPARATOR; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Arm Label: Intensive glycemic control; Type: EXPERIMENTAL; Interventions: Drug: Insulin, Drug: Glimepiride, Drug: Rosiglitazone, Drug: Metformin | Intervention Type: DRUG; Name: Insulin; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control | Intervention Type: DRUG; Name: Glimepiride; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control | Intervention Type: DRUG; Name: Rosiglitazone; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control | Intervention Type: DRUG; Name: Metformin; Assigned to Arm(s): Intensive glycemic control, Standard glycemic control

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase III, Non-inferiority, Double-blind, Unicenter Clinical Trial With Two Treatment Arms - Test Group With Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia
Brief Summary: The primary objective of the study is to determine whether eszopiclone (Eurofarma) is non-inferior to the reference drug zopiclone (Imovane®, Sanofi-Aventis) in the treatment of insomnia.


Options:
A: Arm Label: 1; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Drug: Eszopiclone | Intervention Type: DRUG; Name: Eszopiclone; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 1
B: Arm Label: Eszopiclone 1 mg- Elderly; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone 1 mg- Elderly | Arm Label: Eszopiclone 2 mg- Elderly; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone 2 mg- Elderly | Arm Label: Eszopiclone 2 mg- Non-elderly; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone 2 mg- Non-elderly | Arm Label: Eszopiclone 3 mg- Non-elderly; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone 3 mg- Non-elderly | Intervention Type: DRUG; Name: Eszopiclone 1 mg- Elderly; Assigned to Arm(s): Eszopiclone 1 mg- Elderly | Intervention Type: DRUG; Name: Eszopiclone 2 mg- Elderly; Assigned to Arm(s): Eszopiclone 2 mg- Elderly | Intervention Type: DRUG; Name: Eszopiclone 3 mg- Non-elderly; Assigned to Arm(s): Eszopiclone 3 mg- Non-elderly | Intervention Type: DRUG; Name: Eszopiclone 2 mg- Non-elderly; Assigned to Arm(s): Eszopiclone 2 mg- Non-elderly
C: Arm Label: Eszopiclone 1 mg; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone 1 mg | Arm Label: Eszopiclone 2 mg; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone 2 mg | Arm Label: Eszopiclone 3 mg; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone 3 mg | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: Zolpidem Tartrate 10 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Zolpidem Tartrate 10 mg | Intervention Type: DRUG; Name: Eszopiclone 1 mg; Assigned to Arm(s): Eszopiclone 1 mg | Intervention Type: DRUG; Name: Eszopiclone 2 mg; Assigned to Arm(s): Eszopiclone 2 mg | Intervention Type: DRUG; Name: Eszopiclone 3 mg; Assigned to Arm(s): Eszopiclone 3 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Zolpidem Tartrate 10 mg; Assigned to Arm(s): Zolpidem Tartrate 10 mg
D: Arm Label: eszopiclone 3 mg; Type: EXPERIMENTAL; Interventions: Drug: Eszopiclone | Arm Label: zopiclone 7,5mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Zopiclone | Intervention Type: DRUG; Name: Eszopiclone; Assigned to Arm(s): eszopiclone 3 mg | Intervention Type: DRUG; Name: Zopiclone; Assigned to Arm(s): zopiclone 7,5mg

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of SGN-35 and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Patients at High Risk of Residual Hodgkin Lymphoma Following Autologous Stem Cell Transplant
Brief Summary: This is a randomized, double-blind, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy and safety of brentuximab vedotin (SGN-35) and best supportive care (BSC) compared to placebo and BSC in treatment of residual Hodgkin lymphoma (HL) following autologous stem cell transplant (ASCT).


Options:
A: Arm Label: PET pos; Type: EXPERIMENTAL; Interventions: Drug: ESCALATED BEACOPP | Arm Label: PET negative; Type: OTHER; Interventions: Drug: CONVENTIONAL ABVD | Intervention Type: DRUG; Name: ESCALATED BEACOPP; Assigned to Arm(s): PET pos | Intervention Type: DRUG; Name: CONVENTIONAL ABVD; Assigned to Arm(s): PET negative
B: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: BEACOPP escalated | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Rituximab, Drug: BEACOPP escalated | Arm Label: C; Type: ACTIVE_COMPARATOR; Interventions: Drug: BEACOPP escalated | Arm Label: D; Type: EXPERIMENTAL; Interventions: Drug: BEACOPP escalated | Intervention Type: DRUG; Name: Rituximab; Assigned to Arm(s): B | Intervention Type: DRUG; Name: BEACOPP escalated; Assigned to Arm(s): A, B, C, D
C: Arm Label: Arm A; Type: OTHER; Interventions: Drug: ABVD | Arm Label: Arm B; Type: OTHER; Interventions: Drug: ABVD and Radiotherapy | Intervention Type: DRUG; Name: ABVD; Assigned to Arm(s): Arm A | Intervention Type: DRUG; Name: ABVD and Radiotherapy; Assigned to Arm(s): Arm B
D: Arm Label: Brentuximab vedotin; Type: EXPERIMENTAL; Interventions: Drug: brentuximab vedotin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: brentuximab vedotin; Assigned to Arm(s): Brentuximab vedotin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 4, Randomized, Double-Blind, Multicenter, Placebo-controlled, Parallel Group Study Evaluating the Safety and Efficacy of SPD489 on Executive Function (Self-Regulation) Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) Reporting Clinically Significant Impairment of Real-World Executive Function Behavior.
Brief Summary: The primary objective of the study is to evaluate the efficacy of SPD489 compared to placebo on executive function (self-regulation) behaviors in adults with ADHD who report clinically significant impairment of executive function behavior in their everyday environment, as measured by the self-report Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A) Global Executive Composite (GEC) T-score.


Options:
A: Arm Label: Vyvanse; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vyvanse | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Vyvanse; Assigned to Arm(s): Vyvanse | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: SPD489; Type: ACTIVE_COMPARATOR; Interventions: Drug: SPD489 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo | Intervention Type: DRUG; Name: SPD489; Assigned to Arm(s): SPD489 | Intervention Type: OTHER; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: SPD489; Type: EXPERIMENTAL; Interventions: Drug: SPD489 (Lisdexamfetamine dimesylate) | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: SPD489 (Lisdexamfetamine dimesylate); Assigned to Arm(s): SPD489 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Vyvanse (LDX); Type: EXPERIMENTAL; Interventions: Drug: Lisdexamfetamine Dimesylate | Arm Label: Adderall XR (AXR); Type: EXPERIMENTAL; Interventions: Drug: Adderall XR (mixed salts amphetamine) | Intervention Type: DRUG; Name: Lisdexamfetamine Dimesylate; Assigned to Arm(s): Vyvanse (LDX) | Intervention Type: DRUG; Name: Adderall XR (mixed salts amphetamine); Assigned to Arm(s): Adderall XR (AXR)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Nurse-led Hypertension Clinic in Two Inner City General Practices: Randomised Controlled Trial
Brief Summary: The investigators will do a trial in two general practices to see if the introduction of a blood pressure clinic staffed by a specialist nurse supported by visiting consultant improves blood pressure control compared to usual care.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemonitors and pharmacy management; Type: EXPERIMENTAL; Interventions: Other: Telemonitors and pharmacy management | Intervention Type: OTHER; Name: Telemonitors and pharmacy management; Assigned to Arm(s): Telemonitors and pharmacy management
B: Arm Label: Insulin glargine; Type: OTHER; Interventions: Drug: Insulin glargine | Intervention Type: DRUG; Name: Insulin glargine; Assigned to Arm(s): Insulin glargine
C: Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Nurse-led blood pressure clinic; Type: EXPERIMENTAL; Interventions: Other: Nurse-led blood pressure clinic | Intervention Type: OTHER; Name: Nurse-led blood pressure clinic; Assigned to Arm(s): Nurse-led blood pressure clinic
D: Arm Label: Usual Care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Arm Label: Enhanced pharmacist care; Type: EXPERIMENTAL; Interventions: Other: Enhanced pharmacist care | Intervention Type: OTHER; Name: Enhanced pharmacist care; Assigned to Arm(s): Enhanced pharmacist care | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Usual Care

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR) in Subjects With Heterogeneous Emphysema
Brief Summary: Use of the Chartis® Assessment System prior to EBV Treatment


Options:
A: Arm Label: RePneu Lung Volume Reduction Coil System; Type: EXPERIMENTAL; Interventions: Device: RePneu Lung Volume Reduction Coil System | Arm Label: Control arm is standard medical care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: RePneu Lung Volume Reduction Coil System; Assigned to Arm(s): RePneu Lung Volume Reduction Coil System
B: Arm Label: PLVR; Type: EXPERIMENTAL; Interventions: Device: Polymeric Lung Volume Reduction System (PLVR) | Intervention Type: DEVICE; Name: Polymeric Lung Volume Reduction System (PLVR); Assigned to Arm(s): PLVR
C: Arm Label: Lung volume reduction coïl treatment; Type: EXPERIMENTAL; Interventions: Procedure: Lung volume reduction coïl treatment, Other: Regular medical treatment | Arm Label: Regular Medical Treatment; Type: OTHER; Interventions: Other: Regular medical treatment | Intervention Type: PROCEDURE; Name: Lung volume reduction coïl treatment; Assigned to Arm(s): Lung volume reduction coïl treatment | Intervention Type: OTHER; Name: Regular medical treatment; Assigned to Arm(s): Lung volume reduction coïl treatment, Regular Medical Treatment
D: Arm Label: Chartis System-EBV Treatment; Type: OTHER; Interventions: Device: Chartis System, Device: Endobronchial Valve (EBV) Treatment | Intervention Type: DEVICE; Name: Chartis System; Assigned to Arm(s): Chartis System-EBV Treatment | Intervention Type: DEVICE; Name: Endobronchial Valve (EBV) Treatment; Assigned to Arm(s): Chartis System-EBV Treatment

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Postoperative Blood Transfusion for Frail Elderly With Hip Fracture - a Clinical Randomized Controlled Trial
Brief Summary: Elderly with hip fractures are often frail and discharged from hospital after few days of hospitalisation. Hip fracture surgery is often associated with blood loss, where the patient is at risk of developing anaemia. Low haemoglobin level reduces the body's oxygen transport which causes impaired functional ability and strain on vital organs. Acute anaemia is worse tolerated in elderly, than in younger patients. Therefore this study aims to investigate whether there are effects of an expanded indication for blood transfusion in the frail elderly.


Options:
A: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
B: Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red blood cell transfusion | Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Biological: Red blood cell transfusion | Intervention Type: BIOLOGICAL; Name: Red blood cell transfusion; Assigned to Arm(s): Liberal Transfusion Strategy | Intervention Type: BIOLOGICAL; Name: Red blood cell transfusion; Assigned to Arm(s): Restrictive Transfusion Strategy
C: Arm Label: Restrictive Transfusion Strategy; Type: EXPERIMENTAL; Interventions: Procedure: Transfusion | Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Transfusion | Intervention Type: PROCEDURE; Name: Transfusion; Assigned to Arm(s): Liberal Transfusion Strategy, Restrictive Transfusion Strategy
D: Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Drug: red blood cell transfusion trigger | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Drug: red blood cell transfusion trigger | Intervention Type: DRUG; Name: red blood cell transfusion trigger; Assigned to Arm(s): Liberal, Restrictive

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Postoperative Blood Transfusion for Frail Elderly With Hip Fracture - a Clinical Randomized Controlled Trial
Brief Summary: Elderly with hip fractures are often frail and discharged from hospital after few days of hospitalisation. Hip fracture surgery is often associated with blood loss, where the patient is at risk of developing anaemia. Low haemoglobin level reduces the body's oxygen transport which causes impaired functional ability and strain on vital organs. Acute anaemia is worse tolerated in elderly, than in younger patients. Therefore this study aims to investigate whether there are effects of an expanded indication for blood transfusion in the frail elderly.


Options:
A: Arm Label: Restrictive; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Arm Label: Liberal; Type: EXPERIMENTAL; Interventions: Procedure: Blood Transfusion | Intervention Type: PROCEDURE; Name: Blood Transfusion; Assigned to Arm(s): Liberal, Restrictive
B: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
C: Arm Label: Liberal Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Arm Label: Restrictive Transfusion Strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Red blood cell transfusion | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Liberal Transfusion Strategy | Intervention Type: OTHER; Name: Red blood cell transfusion; Assigned to Arm(s): Restrictive Transfusion Strategy
D: Arm Label: Restrictive transfusion strategy; Type: EXPERIMENTAL; Interventions: Procedure: Restrictive transfusion, Biological: red blood transfusion | Arm Label: Liberal transfusion strategy; Type: EXPERIMENTAL; Interventions: Procedure: Liberal transfusion, Biological: red blood transfusion | Intervention Type: PROCEDURE; Name: Restrictive transfusion; Assigned to Arm(s): Restrictive transfusion strategy | Intervention Type: PROCEDURE; Name: Liberal transfusion; Assigned to Arm(s): Liberal transfusion strategy | Intervention Type: BIOLOGICAL; Name: red blood transfusion; Assigned to Arm(s): Liberal transfusion strategy, Restrictive transfusion strategy

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Postoperative Blood Transfusion for Frail Elderly With Hip Fracture - a Clinical Randomized Controlled Trial
Brief Summary: Elderly with hip fractures are often frail and discharged from hospital after few days of hospitalisation. Hip fracture surgery is often associated with blood loss, where the patient is at risk of developing anaemia. Low haemoglobin level reduces the body's oxygen transport which causes impaired functional ability and strain on vital organs. Acute anaemia is worse tolerated in elderly, than in younger patients. Therefore this study aims to investigate whether there are effects of an expanded indication for blood transfusion in the frail elderly.


Options:
A: Arm Label: Restrictive arm (intervention); Type: EXPERIMENTAL; Interventions: Procedure: Less red blood cell transfusions | Arm Label: Standard care arm (comparator); Type: ACTIVE_COMPARATOR; Interventions: Procedure: More red blood cell transfusion (standard transfusion strategy in PICU) | Intervention Type: PROCEDURE; Name: Less red blood cell transfusions; Assigned to Arm(s): Restrictive arm (intervention) | Intervention Type: PROCEDURE; Name: More red blood cell transfusion (standard transfusion strategy in PICU); Assigned to Arm(s): Standard care arm (comparator)
B: Arm Label: Blood transfusion; Type: EXPERIMENTAL; Interventions: Biological: Blood transfusion | Intervention Type: BIOLOGICAL; Name: Blood transfusion; Assigned to Arm(s): Blood transfusion
C: Arm Label: Liberal transfusion strategy; Type: EXPERIMENTAL; Interventions: Other: Red Blood Cell Transfusions | Arm Label: Restrictive transfusion strategy; Type: ACTIVE_COMPARATOR; Interventions: Other: Red Blood Cell Transfusions | Intervention Type: OTHER; Name: Red Blood Cell Transfusions; Assigned to Arm(s): Liberal transfusion strategy, Restrictive transfusion strategy
D: Arm Label: Liberal; Type: ACTIVE_COMPARATOR; Interventions: Other: Liberal transfusion threshold | Arm Label: Restrictive; Type: ACTIVE_COMPARATOR; Interventions: Other: Restrictive transfusion threshold | Intervention Type: OTHER; Name: Restrictive transfusion threshold; Assigned to Arm(s): Restrictive | Intervention Type: OTHER; Name: Liberal transfusion threshold; Assigned to Arm(s): Liberal

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Clinical and Social-economic Impact Assessment of Robot-assisted Rehabilitation of the Upper Limb in Acute and Subacute Post-stroke Patients
Brief Summary: The goal of this study is to determine if robot aided rehabilitation therapy can be equivalent to or more effective than conventional rehabilitation therapy at promoting functional recovery of the paretic upper limb in acute and subacute stroke patients.


Options:
A: Arm Label: Experimental Group (EG); Type: EXPERIMENTAL; Interventions: Device: Robot therapy (NeReBot), Other: Conventional therapy | Arm Label: Control Group (CG); Type: ACTIVE_COMPARATOR; Interventions: Other: Conventional therapy | Intervention Type: DEVICE; Name: Robot therapy (NeReBot); Assigned to Arm(s): Experimental Group (EG) | Intervention Type: OTHER; Name: Conventional therapy; Assigned to Arm(s): Control Group (CG), Experimental Group (EG)
B: Intervention Type: DEVICE; Name: robotic device; Assigned to Arm(s): N/A
C: Arm Label: Hand Mentor Therapy; Type: EXPERIMENTAL; Interventions: Device: Hand Mentor (TM) robotic stroke therapy device | Arm Label: Control; Type: ACTIVE_COMPARATOR; Interventions: Device: Home Therapy Program | Intervention Type: DEVICE; Name: Hand Mentor (TM) robotic stroke therapy device; Assigned to Arm(s): Hand Mentor Therapy | Intervention Type: DEVICE; Name: Home Therapy Program; Assigned to Arm(s): Control
D: Arm Label: Arm 1; Type: EXPERIMENTAL; Interventions: Device: Robot-Assisted Therapy - MIT-MANUS System | Arm Label: Arm 2; Type: ACTIVE_COMPARATOR; Interventions: Other: Intensive Comparison Therapy | Arm Label: Arm 3; Type: OTHER; Interventions: Other: Usual Care | Intervention Type: DEVICE; Name: Robot-Assisted Therapy - MIT-MANUS System; Assigned to Arm(s): Arm 1 | Intervention Type: OTHER; Name: Intensive Comparison Therapy; Assigned to Arm(s): Arm 2 | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Arm 3

Answer: A